Skip to content

Ayurvedic management of weak bones using Panchatikta Ghrita and Shukti Bhasma

Efficacy of oral administration of Panchatikta Ghrita and Shukti Bhasma in the management of Asthikshaya w.s.r. to Osteopenia/Osteoporosis -An Open Labelled Randomized Standard Controlled Clinical Trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110996
Enrollment
30
Registered
2026-05-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients aged between 30-70 years of either gender 2)Patients with classical signs and symptoms of Asthikshaya like joint pain, backache, tenderness, general debility. 3)Patients of Osteopenia/Osteoporosis (FB83.1) diagnosed by BMD test with score less than -1to -4. 4)Patients willing to participate in study.

Exclusion criteria

Exclusion criteria: 1)Patients with rheumatoid arthritis, gouty arthritis will be excluded. 2)Patients having uncontrolled diabetes mellitus, hypertension and known case of thyrotoxicosis, addisons disease, cushings syndrome, chronic renal disease, hepatic and cardiac failure. 3)Pregnant women and lactating mothers. 4)Patient with a history or evidence of metabolic bone disease eg.hyper or hypoparathyroidism, pagets disease, osteomalacia, renal osteodystrophy, osteogenesis imperfecta. 5)Patient with metastasis of bone who have undergone chemotherapy and radiotherapy. 6)Previous fragility fracture or replacement of both hips. 7)The presence of a prolonged immobility condition eg. spinal cord injury, parkinsons disease, stroke, muscular dystrophy, ankylosing spondylitis.

Design outcomes

Primary

MeasureTime frame
Improvement in t score of BMDTimepoint: 90 days

Secondary

MeasureTime frame
1)Improvement in symptoms of Asthikshaya. 2) Improvement in biomarker of bone turn over P1NP. 3) Improvement in the quality of life. Timepoint: 90 days

Countries

India

Contacts

Public ContactAlisha Ulhas Pol

Institute of Teaching and Research in Ayurveda,Jamnagar

csmehta@itra.edu.in6355432828

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026